Cargando…

Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis

BACKGROUND: Subclinical mastitis is one of the most common reproductive diseases in dairy cows. Qicao Rukang powder is a Chinese herbal compound mixture developed to treat subclinical mastitis in dairy cows by clearing heat, tonifying qi, and improving blood and milk circulation. The study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Bereket H., Oladejo, Ayodele O., Wu, Xiaohu, Yang, Jie, Ma, Xiaoyu, Shen, Wenxiang, Wei, Jiang, Yan, Zuoting, Ding, Xuezhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416365/
https://www.ncbi.nlm.nih.gov/pubmed/34484387
http://dx.doi.org/10.1155/2021/2148186
_version_ 1783748164420894720
author Imam, Bereket H.
Oladejo, Ayodele O.
Wu, Xiaohu
Yang, Jie
Ma, Xiaoyu
Shen, Wenxiang
Wei, Jiang
Yan, Zuoting
Ding, Xuezhi
author_facet Imam, Bereket H.
Oladejo, Ayodele O.
Wu, Xiaohu
Yang, Jie
Ma, Xiaoyu
Shen, Wenxiang
Wei, Jiang
Yan, Zuoting
Ding, Xuezhi
author_sort Imam, Bereket H.
collection PubMed
description BACKGROUND: Subclinical mastitis is one of the most common reproductive diseases in dairy cows. Qicao Rukang powder is a Chinese herbal compound mixture developed to treat subclinical mastitis in dairy cows by clearing heat, tonifying qi, and improving blood and milk circulation. The study aimed to determine the anti-inflammatory and antimicrobial efficacy of Qicao Rukang powder in treating subclinical mastitis in dairy cows at the manufacturer's recommended dose. METHODS: Forty (40) Holstein dairy cows with milk somatic cell count (SCC) ≥ 500,000 cellml(−1) were randomly assigned to treatment (n = 20) and control (n = 20) groups. Cows in the treatment group were administered with 150 grams of Qicao Rukang powder orally for five days, while the control group received no treatment. The authors analyzed the milk SCC, milk composition, bacteriological cure rate of the drug, blood serum levels of interleukins (IL-6, IL-1β, and IL-8), tumor necrosis factor (TNF-α), and interferon gamma (INF-γ) quantified by using ELISA kits on day 0 and day 6. RESULTS: SCC of the treated group reduced very significantly (P < 0.001) compared with the control group. Milk fat, protein, and total solids increased significantly (P < 0.05) after treatment, whereas lactose and milk urea nitrogen levels showed a nonsubstantial rise. The bacteriological cure percentage of Qicao Rukang powder therapy was 77.8% for Aeromonas spp. (14 of 18), 75% for Pseudomonas spp. (6 of 8), and 100% for Acinetobacter spp. and Enterococcus spp. giving 81.8% cured for all isolates (27 of 33). Only 26.7% (8 of 30) of untreated cows recovered spontaneously. Analysis of IL-1β, IL-6, and INF-γ in the blood serum of the treated group revealed a significant decrease (P < 0.01) with nonsignificant rises in TNF-α and IL-8 levels. CONCLUSIONS: This research demonstrates that Qicao Rukang powder has potent antibacterial and anti-inflammatory actions, supporting its use as an alternative to conventional treatment for subclinical dairy cow mastitis. However, further investigations will be required to explain the role of the active ingredients and the mechanisms involved in the pharmacological activities of the Qicao Rukang powder.
format Online
Article
Text
id pubmed-8416365
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84163652021-09-04 Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis Imam, Bereket H. Oladejo, Ayodele O. Wu, Xiaohu Yang, Jie Ma, Xiaoyu Shen, Wenxiang Wei, Jiang Yan, Zuoting Ding, Xuezhi Evid Based Complement Alternat Med Research Article BACKGROUND: Subclinical mastitis is one of the most common reproductive diseases in dairy cows. Qicao Rukang powder is a Chinese herbal compound mixture developed to treat subclinical mastitis in dairy cows by clearing heat, tonifying qi, and improving blood and milk circulation. The study aimed to determine the anti-inflammatory and antimicrobial efficacy of Qicao Rukang powder in treating subclinical mastitis in dairy cows at the manufacturer's recommended dose. METHODS: Forty (40) Holstein dairy cows with milk somatic cell count (SCC) ≥ 500,000 cellml(−1) were randomly assigned to treatment (n = 20) and control (n = 20) groups. Cows in the treatment group were administered with 150 grams of Qicao Rukang powder orally for five days, while the control group received no treatment. The authors analyzed the milk SCC, milk composition, bacteriological cure rate of the drug, blood serum levels of interleukins (IL-6, IL-1β, and IL-8), tumor necrosis factor (TNF-α), and interferon gamma (INF-γ) quantified by using ELISA kits on day 0 and day 6. RESULTS: SCC of the treated group reduced very significantly (P < 0.001) compared with the control group. Milk fat, protein, and total solids increased significantly (P < 0.05) after treatment, whereas lactose and milk urea nitrogen levels showed a nonsubstantial rise. The bacteriological cure percentage of Qicao Rukang powder therapy was 77.8% for Aeromonas spp. (14 of 18), 75% for Pseudomonas spp. (6 of 8), and 100% for Acinetobacter spp. and Enterococcus spp. giving 81.8% cured for all isolates (27 of 33). Only 26.7% (8 of 30) of untreated cows recovered spontaneously. Analysis of IL-1β, IL-6, and INF-γ in the blood serum of the treated group revealed a significant decrease (P < 0.01) with nonsignificant rises in TNF-α and IL-8 levels. CONCLUSIONS: This research demonstrates that Qicao Rukang powder has potent antibacterial and anti-inflammatory actions, supporting its use as an alternative to conventional treatment for subclinical dairy cow mastitis. However, further investigations will be required to explain the role of the active ingredients and the mechanisms involved in the pharmacological activities of the Qicao Rukang powder. Hindawi 2021-08-27 /pmc/articles/PMC8416365/ /pubmed/34484387 http://dx.doi.org/10.1155/2021/2148186 Text en Copyright © 2021 Bereket H. Imam et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Imam, Bereket H.
Oladejo, Ayodele O.
Wu, Xiaohu
Yang, Jie
Ma, Xiaoyu
Shen, Wenxiang
Wei, Jiang
Yan, Zuoting
Ding, Xuezhi
Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title_full Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title_fullStr Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title_full_unstemmed Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title_short Anti-Inflammatory and Antibacterial Potential of Qicao Rukang Powder in Bovine Subclinical Mastitis
title_sort anti-inflammatory and antibacterial potential of qicao rukang powder in bovine subclinical mastitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416365/
https://www.ncbi.nlm.nih.gov/pubmed/34484387
http://dx.doi.org/10.1155/2021/2148186
work_keys_str_mv AT imambereketh antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT oladejoayodeleo antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT wuxiaohu antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT yangjie antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT maxiaoyu antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT shenwenxiang antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT weijiang antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT yanzuoting antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis
AT dingxuezhi antiinflammatoryandantibacterialpotentialofqicaorukangpowderinbovinesubclinicalmastitis